PATENT CLAIM ANALYSIS

Application Number: 15975296
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-09
Patent Classification: ["548", "255000"]

Abstract:
Compounds for targeting and agents for imaging, prostate-specific membrane antigen (PSMA) are disclosed. Methods of synthesizing compounds and imaging agents, as well as methods for imaging PSMA are also disclosed. The imaging agents disclosed are suitable for PET and SPECT imaging.

Claim (Index 12):
The method of  claim 1 , wherein in Formula I, X 5  is C(O), X 13  is C 6 H 6  and X 4  is (CH 2 ) 1-5 , wherein one CH 2  of (CH 2 ) 1-5  is replaced by NH.

Metadata:
- Claim Count in Document: 56.0
- Percentile: 93.0
- Lexical Diversity: 1.71429
- Patent Class: 548.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14917127', '12862955', '12099135', '14152864', '15492933']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7237754361396304
- 35 USC 102 Novelty (BERT): 0.6026264944106694
- Combined Prediction Score: 0.7116605419667343
- Mean Citation Score: 364.583886
- Max Citation Score: 519.5915
- Similarity Product: 467.7924838273227

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test